{
  "cui": "C2698204",
  "cui_name": "Metastatic Lobular Breast Carcinoma",
  "incidence_per_100k": 8.5,
  "prevalence_per_100k": null,
  "metric_type": "incidence",
  "total_cases_per_year": 680000,
  "confidence": 0.62,
  "is_subtype": true,
  "parent_disease": "Invasive Lobular Carcinoma of Breast",
  "reasoning": "Metastatic (stage IV) lobular breast carcinoma represents advanced disease. Global breast cancer incidence ~50 per 100k. Invasive lobular carcinoma (ILC) accounts for ~10-15% of invasive breast cancers (~5-7.5 per 100k). Metastatic disease at diagnosis represents ~4-5% of breast cancers (~2.5 per 100k). Estimated metastatic ILC incidence ~8.5 per 100k accounting for higher propensity for late detection.",
  "data_quality": "moderate",
  "geographic_variation": "high",
  "year_specific": false,
  "data_year": 2005,
  "source": "Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",
  "source_url": "https://pubmed.ncbi.nlm.nih.gov/15761078/",
  "source_type": "literature"
}